SAVA FY 2024 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SAVACassava Sciences, Inc.

$116M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$141M

Net Income

-$24M

EPS (Diluted)

$-0.52

Cash Flow

Operating Cash Flow

-$117M

Free Cash Flow

-$117M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$158M

Total Liabilities

$12M

Stockholders' Equity

$146M

Cash & Equivalents

$129M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$89M	+100.0%
Operating Income	-$141M	-$106M	-33.5%
Net Income	-$24M	-$97M	+75.0%